Showing results (61-70 of 112) with videos related to
Sort By:
Pageof 12
The Journal of Nervous and Mental Disease|December 14, 2006
Cross-cultural differences in somatic presentation in patients with generalized anxiety disorderElizabeth A Hoge, Sharad M Tamrakar, Kelly M Christian, et al.JAMA Psychiatry|August 18, 2020
Efficacy of Yoga vs Cognitive Behavioral Therapy vs Stress Education for the Treatment of Generalized Anxiety Disorder: A Randomized Clinical TrialNaomi M Simon, Stefan G Hofmann, David Rosenfield, et al.Depression and Anxiety|July 19, 2012
Plasma oxytocin immunoreactive products and response to trust in patients with social anxiety disorderElizabeth A Hoge, Elizabeth A Lawson, Christina A Metcalf, et al.The American Journal of Psychiatry|January 9, 2014
A double-blind randomized controlled trial of augmentation and switch strategies for refractory social anxiety disorderMark H Pollack, Michael Van Ameringen, Naomi M Simon, et al.Genomics|July 1, 1996
A 350-kb cosmid contig in 3p14.2 that crosses the t(3;8) hereditary renal cell carcinoma translocation breakpoint and 17 aphidicolin-induced FRA3B breakpointsW Paradee, C M Wilke, L Wang, et al.The Journal of Clinical Psychiatry|September 16, 2004
An open-label study of levetiracetam for the treatment of social anxiety disorderNaomi M Simon, John J Worthington, Alicia C Doyle, et al.Depression and Anxiety|October 28, 2006
Preliminary support for gender differences in response to fluoxetine for generalized anxiety disorderNaomi M Simon, Alyson K Zalta, John J Worthington, et al.Journal of Mood and Anxiety Disorders|March 31, 2025
Neural correlates of reduction in self-judgment after mindful self-compassion training: A pilot study with resting state fMRIDiane Joss, Michael Datko, Charisma I Washington, et al.Biological Psychiatry|September 6, 2005
Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: a placebo controlled studyMark H Pollack, Naomi M Simon, Alyson K Zalta, et al.CNS Neuroscience & Therapeutics|February 21, 2009
Open-label support for duloxetine for the treatment of panic disorderNaomi M Simon, Rebecca E Kaufman, Elizabeth A Hoge, et al.Pageof 12